Tuesday, May 30, 2023
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Infectious Diseases
Department of Health Science
University of Genoa
Head, Infectious Diseases Clinic
Hospital Policlinico San Martino – IRCCS
Genoa, Italy
Professor of Medicine
Director of Research
Division of Infectious Diseases
University of Michigan
Ann Arbor, Michigan
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for infectious disease and critical care specialists.
The goal of this activity is to increase clinicians' knowledge on the latest data for new or emerging antibiotics for the treatment of nosocomial pneumonia (NP).
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Infectious Diseases
Department of Health Science
University of Genoa
Head, Infectious Diseases Clinic
Hospital Policlinico San Martino – IRCCS
Genoa, Italy
Professor of Medicine
Director of Research
Division of Infectious Diseases
University of Michigan
Ann Arbor, Michigan
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-21-024-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 1/20/2021
Valid for credit through: 1/20/2022
processing....
AE = adverse event
BAT = best available therapy
CE = clinically evaluable
CEFT = ceftolozane
cMITT = clinically modified intent-to-treat
CRE = carbapenem-resistant Enterobacteriaceae
ESBL = extended-spectrum beta-lactamase
HABP = hospital-acquired bacterial pneumonia
HAP = hospital-acquired pneumonia
ICU = intensive care unit
ID = infectious disease
IV = intravenous
IMI/REL = imipenem/cilastatin/relebactam
KPC = Klebsiella pneumoniae carbapenemase
LRT = lower respiratory tract
mITT = modified intention to treat
mMITT = microbiologic modified intent to treat
MRSA = methicillin-resistant Staphylococcus aureus
NP = nosocomial pneumonia
NV-ICUAP = non-ventilated intensive care unit-acquired pneumonia
PD = pharmacodynamics
PIP = piperacillin
PK = pharmacokinetics
SAE = serious adverse event
TAZO = tazobactam
TEAE = treatment-emergent adverse event
TOC = test-of-cure
VABP = ventilator-associated bacterial pneumonia
VAP = ventilator-associated pneumonia
VHAP = ventilated hospital-acquired pneumonia
WHO = World Health Organization
| « Return to: Expert to Expert: Updates on New Treatments for Nosocomial Pneumonia |
